SALIX PHARMACEUTICALS LTD Proceeds from Convertible Debt
SALIX PHARMACEUTICALS LTD reported Proceeds from Convertible Debt of $690.00 million for the 12-month period ending 2012-12-31, per its 10-K filed 2015-03-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2015-03-02
- SALIX PHARMACEUTICALS LTD proceeds from convertible debt for the quarter ending 2012-12-31 was $0.00.
- SALIX PHARMACEUTICALS LTD proceeds from convertible debt for the quarter ending 2012-09-30 was $0.00.
- SALIX PHARMACEUTICALS LTD proceeds from convertible debt for the quarter ending 2012-06-30 was $0.00.
- SALIX PHARMACEUTICALS LTD proceeds from convertible debt for the quarter ending 2012-03-31 was $690.00M.
- SALIX PHARMACEUTICALS LTD proceeds from convertible debt for fiscal 2012 was $690.00M.
- SALIX PHARMACEUTICALS LTD proceeds from convertible debt for fiscal 2010 was $345.00M.
| Period end | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 12 month |
|---|---|---|---|---|
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $0.00 derived: sum of 2 quarters · filed 2015-03-02 | $0.00 derived: sum of 3 quarters · filed 2015-03-02 | $690.00M 10-K · filed 2015-03-02 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $0.00 derived: sum of 2 quarters · filed 2013-11-08 | $690.00M 10-Q · filed 2013-11-08 | |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $690.00M 10-Q · filed 2013-08-09 | ||
| 2012-03-31 | $690.00M 10-Q · filed 2013-05-10 | |||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $0.00 derived: sum of 2 quarters · filed 2013-03-01 | $345.00M 10-K · filed 2013-03-01 | |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $345.00M 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | $345.00M 10-Q · filed 2011-08-09 |